| http://www.w3.org/ns/prov#value | - indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company\'s proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).
|
